Benefits and complications of laparoscopic pelvic lymphadenectomy for detection of stage D1 prostate cancer: A multicenter experience

M. Maffezzini, G. Carmignani, M. Perachino, P. Puppo, F. Montorsi, G. Guazzoni, M. Gallucci, F. Di Silverio, M. Morelli, G. Muto

Research output: Contribution to journalArticle

Abstract

One hundred fifty-eight consecutive patients with clinically localized prostate cancer were submitted to staging laparoscopic pelvic lymphadenectomy (LPL) at 5 cooperative centers with one or more of the following conditions which were considered as risk factors for nodal disease: clinical stage C (or T3) disease, serum prostate-specific antigen >20 ng/ml, Gleason sum >6. The mean number of lymph nodes removed was 11 (range 2-29). Metastases from prostate cancer were found in 41 patients (25.9 %). The proportion of lymph node-positive patients increases significantly with the presence of one, two or three of the conditions considered as risk factors (p <0.00005). The benefit of LPL is limited to the lymph node-positive patients who can be spared a second operation.

Original languageEnglish
Pages (from-to)135-137
Number of pages3
JournalEuropean Urology
Volume27
Issue number2
Publication statusPublished - 1995

Keywords

  • Laparoscopic pelvic lymphadenectomy
  • Multicenter experience
  • Prostate cancer staging

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Benefits and complications of laparoscopic pelvic lymphadenectomy for detection of stage D1 prostate cancer: A multicenter experience'. Together they form a unique fingerprint.

  • Cite this

    Maffezzini, M., Carmignani, G., Perachino, M., Puppo, P., Montorsi, F., Guazzoni, G., Gallucci, M., Di Silverio, F., Morelli, M., & Muto, G. (1995). Benefits and complications of laparoscopic pelvic lymphadenectomy for detection of stage D1 prostate cancer: A multicenter experience. European Urology, 27(2), 135-137.